Tripos announces a new program for software developers

NewsGuard 100/100 Score

Tripos™, a leading provider of drug discovery informatics products and services, today announced the creation of a worldwide Benchware® Pantheon™ Partner Program for software developers. The new program will allow third party developers to have direct access to the popular Benchware Pantheon code, opening the way for them to quickly and easily integrate their software tools and solutions into the robust platform.

Benchware Pantheon is a new software solution that enables discovery scientists to rapidly and accurately merge data from multiple sources, and then analyze and visualize that data for faster and better decision making. Researchers can integrate and translate various spreadsheets, merge biological data with chemical structures, and then use a range of tools to sort, analyze and visualize data in 2D and 3D. According to Tripos’ Chief Operating Officer, Patrick Flanagan, “This partnership effort gives creative software developers the perfect environment to combine the inherent power in Benchware Pantheon with their own unique solutions, providing their customers with significant added value.”

Brian Masek, Ph.D., Tripos’ Product Manager and Senior Scientist, says, “Developers understand the potential of Benchware Pantheon and what makes it so unique. The combination of a chemically aware spreadsheet and ‘grid view,’ with powerful 3D molecular visualization, makes it ideal for industry-standard plug-ins. The Pantheon interface allows developers to add their special applications to a universal, extensible platform that accommodates a variety of workflows.”

Developers interested in joining the partnership program are asked to contact Brian Masek for more information and qualification requirements.

Source:

Tripos

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revvity showcases cutting-edge solutions at SLAS2024